Bill > HR1873

This bill aims to educate healthcare providers and the public on biosimilar biological products. The key provisions include: 1. Allowing the Secretary of Health and Human Services to maintain and operate a website to provide educational materials on biological products, including explanations of key terms like "biosimilar" and "interchangeable," information on development programs and reporting adverse events, and the relationship between biosimilar and reference products. 2. Requiring the Secretary to advance education and awareness among healthcare providers on biological products, including biosimilar and interchangeable biosimilar products, by developing or improving continuing education programs. The bill aims to increase understanding and knowledge about biosimilar products, which are highly similar but not identical to reference biological products, in order to promote their appropriate use and improve patient access to more affordable biological treatments.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/1873/all-info